CIM
ALXN
Calvert Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-13,382
| Closed | -$1.64M | – | 684 |
|
|
2016
Q4 | $1.64M | Sell |
13,382
-471
| -3% | -$57.6K | 0.06% | 313 |
|
|
2016
Q3 | $1.7M | Buy |
13,853
+1,069
| +8% | +$131K | 0.06% | 308 |
|
|
2016
Q2 | $1.49M | Buy |
12,784
+453
| +4% | +$52.9K | 0.06% | 293 |
|
|
2016
Q1 | $1.72M | Buy |
12,331
+2,280
| +23% | +$317K | 0.08% | 243 |
|
|
2015
Q4 | $1.92M | Buy |
10,051
+1,790
| +22% | +$341K | 0.09% | 210 |
|
|
2015
Q3 | $1.29M | Buy |
8,261
+1,774
| +27% | +$277K | 0.06% | 192 |
|
|
2015
Q2 | $1.17M | Sell |
6,487
-2,739
| -30% | -$495K | 0.05% | 222 |
|
|
2015
Q1 | $1.6M | Buy |
9,226
+1,424
| +18% | +$247K | 0.1% | 176 |
|
|
2014
Q4 | $1.44M | Buy |
7,802
+624
| +9% | +$115K | 0.1% | 186 |
|
|
2014
Q3 | $1.19M | Buy |
7,178
+5,270
| +276% | +$874K | 0.09% | 191 |
|
|
2014
Q2 | $298K | Hold |
1,908
| – | – | 0.02% | 299 |
|
|
2014
Q1 | $290K | Buy |
1,908
+23
| +1% | +$3.5K | 0.02% | 295 |
|
|
2013
Q4 | $251K | Hold |
1,885
| – | – | 0.02% | 295 |
|
|
2013
Q3 | $219K | Buy |
+1,885
| New | +$219K | 0.03% | 295 |
|